KLK3 and prostate cancer: Routine population screening for breast, cervical, and bowel cancer in Australia results in earlier detection and increased survival [19,20,21,22], and there is evidence that regular skin examinations and risk-appropriate screening through prostate-specific antigen (PSA) testing in men may reduce mortality from melanoma and prostate cancer, respectively [23,24].